Connect to share and comment

HPV-related cancers rose before vaccines hit market

By Andrew M. Seaman NEW YORK (Reuters Health) - The number of some cancers related to the human papillomavirus (HPV) increased throughout the U.S. before vaccines against the sexually transmitted infection were available, says to a new study. Researchers found an increase in many early-stage cancers and anal and head and neck late-stage cancers across the U.S. between 1978 through 2007 that are thought to be related to the infection.
Syndicate content